Search Results
Apr 30, 2026, 16:00 ET FiEE, Inc. Announces First Quarter 2026 Unaudited Financial Results
(i) the future financial position and performance of the Company, (ii) our ability to successfully implement our strategic business transformation, (iii) our long-term growth objectives and opportunities, (iv) our commitment to investing in R&D to expand our service offerings, enhance customer experience,
More news about: FiEE, Inc.
Apr 30, 2026, 15:28 ET SCENTRE GROUP ANNOUNCES CONSIDERATION FOR TENDER OFFER
reserves the right, subject to applicable law, to (i) waive any and all conditions to the Tender Offer, (ii) extend or terminate the Tender Offer, or (iii) otherwise amend the Tender Offer in any respect.Dealer Managers and Tender and Information AgentThe Offeror has appointed Merrill
More news about: Scentre Group
Apr 30, 2026, 14:29 ET Norgine annuncia l'autorizzazione all'immissione in commercio da parte della Commissione europea per XOLREMDI ® (mavorixafor), la prima terapia autorizzata per i pazienti con sindrome WHIM nell'Unione Europea
possibile".L'autorizzazione all'immissione in commercio da parte della Commissione europea si basa sui risultati dello studio clinico pivotale di fase III WHIM, uno studio multicentrico globale, randomizzato, in doppio cieco, controllato con placebo, di 52 settimane che ha valutato l'efficacia e la sicurezza
More news about: Norgine B.V.
Apr 30, 2026, 12:45 ET SuperOrdinary to redefine its creator commerce ecosystem by inviting its creator community to become shareholders
of the Securities Act and will not be required to comply with specific disclosure requirements that apply to registration under the Securities Act; (iii) the United States Securities and Exchange Commission will not pass upon the merits of or give its approval to the securities, the terms of the offering,
More news about: SuperOrdinary
Apr 30, 2026, 12:38 ET Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
(GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval
More news about: Northwest Biotherapeutics, Inc.
Apr 30, 2026, 12:30 ET Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
(GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval
More news about: Northwest Biotherapeutics, Inc.
Apr 30, 2026, 12:16 ET Boyne Capital Closes Oversubscribed BCM Fund III at over $400 Million
pleased to announce the first and final closing of its third investment fund, BCM Fund III, LP ("BCM Fund III" or "Fund III"). Fund III was oversubscribed and closed at its hard cap with total limited partner commitments of $355 million,
More news about: Boyne Capital
Apr 30, 2026, 12:12 ET Shrub Oak International School Expands Innovative Program for DeafDisabled Students
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on Elementary and Secondary
More news about: Shrub Oak International School
Apr 30, 2026, 12:00 ET Reverence Capital Partners Closes More Than $2 Billion Recapitalization of Osaic
investment firm focused on three complementary strategies: (i) financial services-focused private equity, (ii) opportunistic, structured credit, and (iii) real estate solutions. Today, Reverence Capital manages in excess of $14 billion in AUM. Reverence focuses on thematic investing in leading global financial
More news about: Reverence Capital Partners
Apr 30, 2026, 11:42 ET The Camera Is the New Sensor: Why a Provisional Patent Filing in Hollywood Could Reshape How the Pentagon Buys Vision
issued claims of commercial value; (ii) technical, regulatory, and market risks associated with the development and commercialization of xCalibre™; (iii) the Company's ability to secure government contracts; (iv) competition; (v) dependence on key personnel; and (vi) general economic and defense-budget
More news about: Equity Insider
Apr 30, 2026, 10:55 ET HCLTech expands Cornerstone Partnership with MetLife Stadium, New York Jets and New York Giants as an Official AI Partner
the 1968 season, the team made history by becoming the first AFL franchise to win a world championship, defeating the Baltimore Colts in Super Bowl III—a victory widely credited with validating the AFL ahead of its 1970 merger with the NFL. Today, as one of the league's flagship franchises in the nation's
More news about: HCLTech
Apr 30, 2026, 10:38 ET El primer fármaco recombinante de toxina botulínica tipo A del mundo obtiene la autorización de comercialización en China: una revolución tecnológica impulsada por Claruvis Pharmaceutical
derivada del Clostridium botulinum, y ofrece una toxina de alta pureza y alta actividad específica.En un ensayo clínico multicéntrico de fase III, aleatorizado, doble ciego y controlado con placebo y fármaco activo, realizado en China, Retoxin® alcanzó todos los criterios de valoración
More news about: Claruvis Pharmaceutical
Apr 30, 2026, 09:50 ET CWH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Camping World Holdings (CWH) Investors of Securities Class Action Deadline on May 11, 2026
optimize profit using "data analytics;" (ii) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, the Company would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; (iv) the
More news about: Faruqi & Faruqi, LLP
Apr 30, 2026, 09:41 ET ATTENTION NYSE: SES INVESTORS: Contact Berger Montague About an SES AI Corporation Class Action Lawsuit
circular counterparties; (ii) the Company faced operational constraints that undermined its ability to generate the revenues it had projected; and (iii) underlying demand for SES AI's products was deteriorating.On December 9, 2025, Wolfpack Research published a report alleging that SES AI had
More news about: Berger Montague
Apr 30, 2026, 09:38 ET ODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Oddity Tech (ODD) Investors of Securities Class Action Deadline on May 11, 2026
the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and
More news about: Faruqi & Faruqi, LLP
Apr 30, 2026, 09:26 ET PINS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Pinterest (PINS) Investors of Securities Class Action Deadline on May 29, 2026
reallocating resources to AI-focused roles and teams that drive AI adoption and execution, (ii) prioritizing AI powered products and capabilities, and (iii) accelerating the transformation of its sales and go-to-market approach."On this news, Pinterest's stock price fell $2.49 per share, or 9.61%,
More news about: Faruqi & Faruqi, LLP
Apr 30, 2026, 09:07 ET JASMINE Trial Demonstrates Prolacta's Human Milk-Based Fortifiers Deliver Superior Growth in Premature Infants While Maintaining Japan's Renowned Low NEC Rate
Mizuno K, Miyazawa T, Kondo U, et al. Growth and safety evaluation in very low birth weight infants receiving an exclusive human milk diet: a phase III randomized control trial in Japan. J Perinatol. Published online April 27, 2026. doi:10.1038/s41372-026-02695-w
More news about: Prolacta Bioscience
Apr 30, 2026, 09:00 ET TIAA Clients Win Three First-Place Honors for RetirePlus Rollout at 2026 Pensions & Investments Eddy Awards
products.iii.As of March 31,
More news about: TIAA
Apr 30, 2026, 09:00 ET HCLTech expands Cornerstone Partnership with MetLife Stadium, New York Jets and New York Giants as an Official AI Partner
the 1968 season, the team made history by becoming the first AFL franchise to win a world championship, defeating the Baltimore Colts in Super Bowl III—a victory widely credited with validating the AFL ahead of its 1970 merger with the NFL. Today, as one of the league's flagship franchises in the nation's
More news about: New York Jets
Apr 30, 2026, 09:00 ET GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Patient Enrollment Quality: SueWallSt
creating a heavily-treated population profile61% were on background prostacyclin therapy, further distinguishing this cohort from typical Phase III PAH baselinesLatin American sites produced near-parity between placebo and treatment response rates, as alleged, compressing the
More news about: SueWallSt.com
Apr 30, 2026, 09:00 ET ORMCO™ EXPANDS DIGITAL BONDING TO MORE ORTHODONTIC BRACKET SYSTEMS AT AAO 2026
in treating their patients.iii Wires are not included with ODB.iv The
More news about: Ormco Corporation
Apr 30, 2026, 09:00 ET CULLEN/FROST REPORTS FIRST QUARTER RESULTS
of 2026 were 14.07 percent, 14.51 percent and 15.89 percent, respectively, and continue to be in excess of well-capitalized levels and exceed Basel III minimum requirements.Net interest income on a taxable-equivalent basis was $460.8 million for the first quarter of 2026, an increase of 5.6
More news about: Cullen/Frost Bankers, Inc.
Apr 30, 2026, 09:00 ET Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting
(i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue
More news about: Astellas Pharma Inc.
Apr 30, 2026, 08:45 ET Brand Engagement Network (NASDAQ: BNAI) Signs Definitive Agreement to Acquire Cataneo GmbH, a Global Media Infrastructure Leader, in a Debt-Free $19.5 Million Transaction
of the Cataneo Acquisition; (ii) the risk that the Cataneo Acquisition may not be completed on the anticipated terms in a timely manner or at all; (iii) the failure to satisfy any of the conditions to the consummation of the Cataneo Acquisition, including the ability to obtain financing to fund the Cataneo
More news about: Brand Engagement Network, Inc. (BEN)
Apr 30, 2026, 08:30 ET NNN REIT, Inc. Announces First Quarter 2026 Results and Increases 2026 Guidance
produces an annualized amount as of a point in time but does not take into consideration future (i) scheduled rent increases, (ii) leasing activity, or (iii) lease expirations.Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate ("EBITDAre") as defined by the National
More news about: NNN REIT, Inc.